Telotristat ethyl in carcinoid syndrome: safety and efficacy in the TELECAST phase 3 trial.

about

In Reply: Telotristat Ethyl for Patients With Carcinoid Syndrome Associated With Chest Pain and Hypertension

P2860

Q58700246-AF557809-4E94-4137-B454-F447D8196DA7

P2860

Telotristat ethyl in carcinoid syndrome: safety and efficacy in the TELECAST phase 3 trial.

Item

http://www.wikidata.org/entity/Q50059510

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Telotristat ethyl in carcinoid ...... in the TELECAST phase 3 trial.

@en

Telotristat ethyl in carcinoid ...... in the TELECAST phase 3 trial.

@nl

type

Item

label

Telotristat ethyl in carcinoid ...... in the TELECAST phase 3 trial.

@en

Telotristat ethyl in carcinoid ...... in the TELECAST phase 3 trial.

@nl

prefLabel

Telotristat ethyl in carcinoid ...... in the TELECAST phase 3 trial.

@en

Telotristat ethyl in carcinoid ...... in the TELECAST phase 3 trial.

@nl

P1476

Telotristat ethyl in carcinoid ...... in the TELECAST phase 3 trial.

@en

P2093

David J Gross

http://www.w3.org/2001/XMLSchema#string

Dieter Hörsch

http://www.w3.org/2001/XMLSchema#string

Douglas Fleming

http://www.w3.org/2001/XMLSchema#string

Kenneth Kassler-Taub

http://www.w3.org/2001/XMLSchema#string

Lowell B Anthony

http://www.w3.org/2001/XMLSchema#string

Marianne Pavel

http://www.w3.org/2001/XMLSchema#string

Marta Benavent

http://www.w3.org/2001/XMLSchema#string

Martin O Weickert

http://www.w3.org/2001/XMLSchema#string

Matthew H Kulke

http://www.w3.org/2001/XMLSchema#string

Pablo Lapuerta

http://www.w3.org/2001/XMLSchema#string

P2860

Carcinoid heart disease: presentation, diagnosis, and management

Somatostatin analogues in acromegaly and gastroenteropancreatic neuroendocrine tumours: past, present and future

Functional bowel disorders

Discovery and characterization of novel tryptophan hydroxylase inhibitors that selectively inhibit serotonin synthesis in the gastrointestinal tract.

Fibrosis and carcinoid syndrome: from causation to future therapy.

Review article: somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine (carcinoid) tumours.

The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the Jejunum, Ileum, Appendix, and Cecum.

Frequency of carcinoid syndrome at neuroendocrine tumour diagnosis: a population-based study.

Diagnosing and Managing Carcinoid Heart Disease in Patients With Neuroendocrine Tumors: An Expert Statement.

Rapid and sustained relief from the symptoms of carcinoid syndrome: results from an open 6-month study of the 28-day prolonged-release formulation of lanreotide.

P304

309-322

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1530/ERC-17-0455

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Rocío García-Carbonero

P577

2018-01-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29330194

http://www.w3.org/2001/XMLSchema#string

P921

phase III clinical trial

P932

5811631

http://www.w3.org/2001/XMLSchema#string

Telotristat ethyl in carcinoid syndrome: safety and efficacy in the TELECAST phase 3 trial.

about

P2860

P2860

Telotristat ethyl in carcinoid syndrome: safety and efficacy in the TELECAST phase 3 trial.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932